![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 51, 36790-36795, December 17, 1999
From the Department of Biochemistry, The Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan
| |
ABSTRACT |
|---|
|
|
|---|
We have cloned a novel inositol polyphosphate
5-phosphatase from the rat brain cDNA library. It contains two
highly conserved 5-phosphatase motifs, both of which are essential for
its enzymatic activity. Interestingly, the proline content of this
protein is high and concentrated in its N- and C-terminal regions. One
putative SH3-binding motif and six 14-3-3 Inositol and phosphatidylinositol polyphosphates play important
roles in a variety of signal transduction systems. Therefore, intracellular levels of these second messenger molecules are thought to
be tightly controlled and promptly changed by the enzymes in response
to extracellular stimuli. Inositol polyphosphate 5-phosphatase is the
enzyme that specifically hydrolyzes phosphate at the D-5 position of
inositol or phosphatidylinositol polyphosphates and has been conserved
from yeast to human. Seven different enzymes and numerous splicing
isoforms have been isolated in mammals (1-15). All 5-phosphatases
possess two highly conserved catalytic motifs and are classified into
three groups based on their substrate specificity. 1) Type I
5-phosphatase; this enzyme hydrolyzes only water-soluble substrates
such as
Ins(1,4,5)P31 and
Ins(1,3,4,5)P4 (3, 16). 2) SHIP 1 (for SH2 containing inositol polyphosphate 5-phosphatase 1) and SHIP 2; SHIP 1 selectively dephosphorylates Ins(1,3,4,5)P4 and
PtdIns(3,4,5)P3 that contain phosphate at the D-3 position
of the inositol ring (5, 7, 8). SHIP 2 hydrolyzes
PtdIns(3,4,5)P3, but its Ins(1,3,4,5)P4 phosphatase activity has not been confirmed (17, 18). 3) Type II
5-phosphatase, OCRL, synaptojanin and synaptojanin 2; these enzymes exhibit broad substrate specificity. They hydrolyze
water-soluble substrates such as Ins(1,4,5)P3 and
Ins(1,3,4,5)P4 and lipid substrates such as
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 (6, 11, 12,
16, 19-22). Synaptojanin 2 is a recently discovered 5-phosphatase, and
its catalytic motifs are identical to synaptojanin (11, 12). OCRL was
identified as a causative gene of Low's oculocerebrorenal syndrome, an
X chromosome-linked developmental disorder (2). OCRL showed a strong
preference for lipid substrate (16). The cells derived from the Low's
oculocerebrorenal syndrome patient were defective in OCRL activity and
accumulated 2-3-fold more PtdIns(4,5)P2 than normal cells
(20).
There is evidence that phosphatidylinositol polyphosphates such
as PtdIns(4,5)P2 and PtdIns(3,4,5)P3 play
important roles in the regulation of the actin cytoskeleton (22-24).
PtdIns(4,5)P2 binds to actin-binding proteins such as
vinculin, Here, we report the cloning and characterization of a novel
5-phosphatase. This enzyme dephosphorylates the D-5 position of inositol and phosphatidylinositol polyphosphates at ruffling membranes.
Molecular Cloning of the Rat Novel Inositol Polyphosphate
5-Phosphatase--
A partial human cDNA clone
(GenBankTM accession number H14886) was obtained from
Genome System, Inc. (St. Louis, MO). H14886 is a 468-base pair human
cDNA fragment, and its deduced amino acid sequence contains a
5-phosphatase catalytic motif2-like sequence. The fragments were
labeled by random hexamer priming and used to screen a Northern Blot Analysis--
Membranes containing mRNA (2 µg of poly(A) RNA was contained in each lane) were purchased from
OriGene Technology, Inc. (Rockville, MD). Total RNA was isolated from
cultured cells using MagExtractor-RNA- and MagExtractor System (TOYOBO
Co., Ltd., Osaka, Japan), and approximately 10 µg of the RNA was
blotted on a nylon membrane. The sequence of rat novel 5-phosphatase
specific region, nucleotides 2362-3000, was amplified by polymerase
chain reaction and used as an [ Cell Culture and Expression of Recombinant Proteins in COS-7
Cells--
COS-7 cells were cultured in Dulbecco's modified Eagle's
medium (Nissui, Tokyo, Japan) containing 10% fetal calf serum and 60 µg/ml kanamycin, and kept at 37 °C in a humidified atmosphere of
95% air and 5% CO2. Rat novel 5-phosphatase cDNA, its
deletion mutants and partial human SHIP 1 cDNA (nucleotides
1461-4079 of human SHIP 1 cDNA; GenBankTM accession
number U57650) were subcloned into the eukaryotic pCMV6-Myc expression
vector. Constitutively active Rac1, Rac1G12V construct, was ligated
into the eukaryotic pEF-BOS-FLAG expression vector. All constructs were
transfected into COS-7 cells by a conventional electroporation method,
and cells were harvested or fixed after 48 h (22). The expression
and the size of expressed proteins were checked by immunoblotting.
Dephosphorylation of Novel Inositol Polyphosphate 5-Phosphatase
Protein--
Recombinant novel 5-phosphatase expressing cells (1 × 106 cells/60-mm tissue culture dish (Falcon)) were
washed once with PBS( Enzyme Assay--
Cells (7 × 106 cells/150-mm
tissue culture dish (Falcon)) transfected with Myc-epitope-tagged novel
5-phosphatase construct or empty vector were cultured for 2 days and
harvested with 1 ml of cold lysis buffer (40 mM Tris-HCl,
pH 7.6, 150 mM NaCl, 2 mM EDTA, 1% Triton
X-100, 10 µg/ml leupeptin, and 10 µg/ml aprotinin). The cells were
briefly sonicated and centrifuged at 10,000 × g for 20 min at 4 °C. Supernatant was collected and rotated with 25 µl of
anti-Myc monoclonal antibody (Santa Cruz Biotechnology, Inc.) for
1 h at 4 °C. Then protein A beads (Pierce) (50 µl) were added, and the solution was rotated for 1 h. After that, the beads were washed with lysis buffer five times and finally suspended in
buffer for inositol polyphosphates or PtdIns(4,5)P2
phosphatase assay.
Assay of inositol polyphosphate 5-phosphatase activity was carried out
as described by Connolly et al. (36) using
[3H]Ins(1,3,4)P3,
[3H]Ins(1,4,5)P3, and
[3H]Ins(1,3,4,5)P4. The separation of
inositol polyphosphates by high performance liquid chromatography was
done according to the method of Zhang and Buxton (37). The flow rate
was 0.6 ml/min, and each fraction was collected for 30 s.
Collected samples were diluted to 1/20 volume with distilled water and
quantitated by liquid scintillation counting. For the assay of
Ins(1,3,4)P3 hydrolyzing activity, the D-5 position
phosphate of Ins(1,3,4,5)P4 was hydrolyzed by recombinant
SHIP 1 protein and used as a substrate. The SHIP 1 protein was prepared
the same way as the novel 5-phosphatase.
The PtdIns(4,5)P2 phosphatase activity was determined (38).
The spots on the thin layer chromatography plate were visualized by
exposing the plate to x-ray film (Eastman Kodak Scientific Co.,
Rochester, NY) for 6 days at Cell Staining--
Transfected cells cultured on glass
coverslips were fixed with 10% formaldehyde in PBS( cDNA Cloning of the Novel Inositol Polyphosphate
5-Phosphatase--
The predicted amino acid sequence of human EST
clone H14886 is very similar to OCRL and synaptojanin, and contains the 5-phosphatase catalytic motif2-like sequence (2, 6). Therefore, we regarded H14886 as a partial cDNA fragment of a novel
5-phosphatase. Using H14886 as a probe, we obtained several cDNA
clones from a rat brain cDNA library and isolated a 3,322-base pair
rat putative 5-phosphatase cDNA (Fig.
1). Our rat cDNA clone contained the polyadenylation signal AATTAAA (nucleotides 3304-3310) (Fig. 1). The
same polyadenylation signal and poly(A) sequence are found in another
1496-base pair human EST clone, U45975. There was no in-frame upstream
stop codon in our cDNA clone. However, we concluded that the ATG
underlined in Fig. 1 is the initiation codon for rat putative
5-phosphatase mRNA because 1) the sequence around the first
putative ATG codon agrees with Kozak's consensus rule
(GCAGACATGG versus GCC(G/A)CCATGG)
(39), and 2) Northern blot analysis indicated that the rat putative
5-phosphatase mRNA is 3.4-kb long, which is nearly identical to the
length of our cDNA clone (Fig. 4). Searches of the current
GenBankTM data base with BLASTN algorithm revealed that
part of synaptojanin and synaptojanin 2 are homologous to the
1900-2040-base pair region of the rat putative 5-phosphatase cDNA
sequence (60 and 69%, respectively), which includes the 5-phosphatase
catalytic motif2.
Features of the Amino Acid Sequence of the Novel Inositol
Polyphosphate 5-Phosphatase and Its Recombinant Protein--
The
putative amino acid sequence of the 5-phosphatase cDNA indicates
that it is a proline-rich 5-phosphatase with a molecular mass of 107 kDa (Fig. 1). Usually, the average proline content of proteins in
eukaryotes is 4-5% (40), but that of putative 5-phosphatase is 13.3%
and concentrated in its N- and C-terminal regions (Fig. 1). The
N-terminal proline-rich region contains 21.0% and the C-terminal
region 18.4% proline. In contrast, type I 5-phosphatase contains 3.9%
proline, SHIP 1, 8.0%; SHIP 2, 9.3%; type II 5-phosphatase, 4.5%;
OCRL, 6.2%; synaptojanin, 7.0%; and synaptojanin 2, 4.5%. Therefore,
we designated the putative 5-phosphatase as PIPP
(proline-rich inositol
polyphosphate 5-phosphatase). The N-terminal
proline-rich region contained one putative SH3-binding motif, PRSPSR
(Fig. 1) (41, 42). Recently, it was reported that type I 5-phosphatase
was activated when it bound to platelet protein, pleckstrin, or 14-3-3
When recombinant PIPP protein was expressed in COS-7 cells and analyzed
by immunoblotting, two bands were detected (Fig.
3). Treatment of cell lysate with
alkaline phosphatase reduced the upper band indicating that a part of
the ectopically expressed PIPP is phosphorylated. The molecular mass of
PIPP was estimated at about 107 kDa from its amino acid sequence but
the dephosphorylated PIPP still seemed slightly larger in
SDS-polyacrylamide gel electrophoresis (Fig. 3). This may be due to the
proline-rich sequence of PIPP (40).
Our results suggest that recombinant PIPP is highly phosphorylated in
the cytoplasm. But Western blot analysis revealed that anti-phosphotyrosine antibody (PY20) did not stain phosphorylated PIPP
(data not shown). Therefore, PIPP is probably phosphorylated at
serine/threonine residues, which might regulate the activity.
Northern Blot Analysis--
The results of Northern blot analysis
are shown in Fig. 4. PIPP was expressed
in brain, heart, kidney, stomach, small intestine, and lung. The size
of the mRNA was estimated at 3.4 kb in those tissues. In spleen,
thymus, skeletal muscle, testis, and skin, no signal was observed. All
cultured cells examined expressed PIPP, but Jurkat and HL-60 cells
showed an especially high PIPP mRNA content. Only liver showed the
2.4-kb band. This signal might indicate the existence of a splicing
isoform of the PIPP or another undiscovered 5-phosphatase in liver.
Enzymatic Activity--
Myc-epitope-tagged PIPP was expressed in
COS-7 cells and purified by immunoprecipitation using anti-Myc
monoclonal antibody. When Ins(1,4,5)P3 was incubated with
recombinant PIPP and the mixture was analyzed by high performance
liquid chromatography, two peaks were observed (Fig.
5A). The retention time of
these two peaks indicated that the former was inositol bisphosphate and
the latter was substrate, Ins(1,4,5)P3 (37). PIPP
hydrolyzed Ins(1,4,5)P3 to inositol bisphosphate and also
removed one phosphate from Ins(1,3,4,5)P4 and produced
inositol trisphosphate (Fig. 5B). To determine which
phosphate was hydrolyzed by PIPP, Ins(1,3,4)P3 was
incubated with PIPP, but no hydrolysis was observed in this case (Fig.
5C). These results indicate that PIPP specifically hydrolyzes phosphate at the D-5 position in Ins(1,4,5)P3
and Ins(1,3,4,5)P4.
The catalytic motifs of PIPP are very similar to OCRL and synaptojanin.
These 5-phosphatases hydrolyze inositol polyphosphates as well as
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 (16, 19-22).
We also checked the lipid phosphatase activity of PIPP. As shown in
Fig. 6, when
[3H]PtdIns(4,5)P2 was incubated with PIPP,
[3H]phosphatidylinositol monophosphate was formed. When
the phosphate at the D-5 position of PtdIns(4,5)P2 was
labeled with 32P and incubated with PIPP,
[32P]phosphatidylinositol monophosphate was not formed
(data not shown), showing that PIPP has lipid phosphatase activity and
can hydrolyze phosphate at the D-5 position of
PtdIns(4,5)P2. Thus, according to the substrate
specificity, PIPP is classified with type II 5-phosphatase, OCRL,
synaptojanin, and synaptojanin 2 (21).
Overexpression of PIPP and Its Deletion Mutants in COS-7
Cells--
Myc-epitope-tagged PIPP was expressed in COS-7 cells, and
its cellular localization was revealed by anti-Myc polyclonal antibody. As indicated in Fig. 7A, some
PIPP was clearly condensed at the cell periphery and some dispersed in
the cytoplasm. The same cells were stained with rhodamine-phalloidin to
visualize the actin cytoskeleton (Fig. 7B). Some PIPP was
localized in cortical areas with the actin filaments locating at
ruffling membranes. However, alterations in the actin cytoskeleton were
not observed, in contrast to reports on overexpression of OCRL and
synaptojanin in cells (22, 47).
We prepared several deletion mutants of PIPP to determine the region
essential for its localization to ruffling membranes and co-expressed
it with constitutively active Rac1 mutant in COS-7 cells (Fig.
8, panel I).
Constitutively active Rac1 mutant co-localizes with actin filaments at
ruffling membranes and accelerates membrane ruffling (48, 49).
Apparently, PIPP co-localized with the active Rac1 mutant (Fig. 8,
panel II, A and B) confirming that
PIPP localizes at ruffling membranes. Mut2 and Mut3 exhibited the same
localization pattern as the full-length of PIPP (data not shown).
Truncated PIPP without the N-terminal proline-rich region (Mut4)
located to membrane ruffles at a much lower intensity than wild type or
mutants with partial proline-rich regions (Mut2 and Mut3, Fig. 8,
panel II, C and D). When the C-terminal
proline-rich region containing 277 amino acids (725-1001) was deleted
(Mut6), the localization of the enzyme to the ruffling membranes was
abolished (Fig. 8, panel II, E and F). Mut5 did
not contain either the N- or C-terminal proline-rich regions and did
not localize to ruffling membranes (Fig. 8, panel II,
G and H). These results indicate that the
C-terminal proline-rich region from residues 725 to 1001 is essential
for the localization of PIPP to ruffling membranes and a part of the
N-terminal proline-rich region from residues 311 to 433 contributes to
the localization. PIPP contains one putative SH3-binding motif and five
14-3-3
Mut1 did not contain the two catalytic motifs of 5-phosphatase
localized to ruffling membranes (Fig. 8, panel II,
I and J). Membrane ruffling, induced by
constitutively active Rac1 mutant, was not affected by the
co-expression of any deletion mutants of PIPP (Fig. 8, panel II,
B, D, F, H, and J).
These results indicate that PIPP does not participate in the
re-organization of the actin cytoskeleton but may be involved in
modulation of the function of inositol and phosphatidylinositol
polyphosphate-binding proteins that are present at membrane ruffles.
In summary, we have cloned a novel 5-phosphatase from a rat brain
cDNA library. It is a proline-rich protein and hydrolyzed the D-5
position of phosphate in Ins(1,4,5)P3,
Ins(1,3,4,5)P4 and PtdIns(4,5)P2. Therefore, we
designated this novel 5-phosphatase as PIPP. PIPP is localized at
membrane ruffles and may be involved in the modulation of the function
of proteins that are present at membrane ruffles.
-binding motifs were
found in the amino acid sequence. This enzyme hydrolyzed phosphate at
the D-5 position of inositol 1,4,5-trisphosphate, inositol
1,3,4,5-tetrakisphosphate, and phosphatidylinositol 4,5-bisphosphate,
consistent with the substrate specificity of type II 5-phosphatase,
OCRL, synaptojanin and synaptojanin 2, already characterized
5-phosphatases. When the Myc-epitope-tagged enzyme was expressed in
COS-7 cells and stained with anti-Myc polyclonal antibody, a signal was
observed at ruffling membranes and in the cytoplasm. We prepared
several deletion mutants and demonstrated that the 123 N-terminal amino acids (311-433) and a C-terminal proline-rich region containing 277 amino acids (725-1001) were essential for its localization to ruffling
membranes. This enzyme might regulate the level of inositol and
phosphatidylinositol polyphosphates at membrane ruffles.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-actinin, profilin, and gelsolin, and promotes actin
filament formation (25-27). Of the seven distinct 5-phosphatases, only
synaptojanin has been demonstrated to hydrolyze
PtdIns(4,5)P2 bound to actin regulatory proteins such as
vinculin,
-actinin, and profilin in vitro (22). In
addition, it has been shown that PtdIns(4,5)P2 and
PtdIns(3,4,5)P3 modulate the function of various proteins
such as protein kinase C (28), phospholipase D (29, 30), protein kinase
B/Akt (31), ATP-sensitive potassium channel (32-34), and
ADP-ribosylation factor (35). Therefore, it is plausible that lipid
phosphatase, like OCRL and synaptojanin, hydrolyzes those
phosphatidylinositol polyphosphates and plays an important role in the
actin depolymerization mechanism as well as other functions.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
ZAPII rat
brain cDNA library (Stratagene, La Jolla, CA). Positive clones were
subcloned into pBluescript SK(
) by an in vivo excision
method and sequenced. Complete sequence data was obtained from both
strands using a conventional dideoxy-termination method.
-32P]dCTP-labeled
0.7-kb cDNA probe. Hybridization was performed following the
protocol of OriGene Technology, Inc., and the probe was hybridized at
42 °C.
) and harvested with 200 µl of the reaction
buffer for alkaline phosphatase (50 mM Tris-HCl, pH 7.5, 1 mM MgCl2, 10 µg/ml leupeptin, and 10 µg/ml
aprotinin). After a brief sonication, the cell lysate was incubated for
10 min at 30 °C. Then 100 µl of the lysate with or without 30 units of calf intestine alkaline phosphatase (Takara Shuzo Co., Ltd.,
Biomedical Group, Shiga, Japan) was further incubated for 15 min at the
same temperature. The mixture was analyzed by immunoblotting.
80 °C. Before the exposure, the
intensity of the radioactivity was enhanced by EN3HANCE
spray (NEN Life Science Products).
) for 10 min at
room temperature and washed three times with PBS(
). Then they were
incubated for 5 min in 0.2% Triton X-100 in PBS(
) at room
temperature and washed with PBS(
) five times. The cells were further
incubated with anti-Myc polyclonal antibody (Santa Cruz Biotechnology,
Inc.) for 1 h. After five washes with PBS(
), the cells were
incubated with fluorescein isothiocyanate-conjugated anti-rabbit IgG
antibody (ICN Pharmaceuticals, Inc., Costa Mesa, CA) and
rhodamine-phalloidin (Molecular Probes, Eugene, Oregon) for 30 min.
When active Rac was co-transfected, anti-FLAG monoclonal antibody
(Eastman Kodak Scientific Co.) and anti-Myc polyclonal antibody were
used as primary antibodies and rhodamine-conjugated anti-mouse IgG
antibody (ICN Pharmaceuticals, Inc.) was substituted with
rhodamine-phalloidin. The cells were mounted in glycerin-PBS(
) and
observed with a fluorescence microscope.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (79K):
[in a new window]
Fig. 1.
Nucleotide and corresponding amino acid
sequence of PIPP cDNA. The proline residues are indicated by
shaded boxes. Characteristic amino acid sequences of
5-phosphatase are boxed. The putative ATG start codon, TGA
stop codon and AATTAAA polyadenylation signal are
underlined. The amino acid numbers are indicated in the
right margin, and nucleotide numbers in the left
margin. The N-terminal proline-rich region is from amino acid 1 to
433 and the C-terminal region is from amino acid 866 to 1001. A
putative SH3-binding motif is located in the N-terminal proline-rich
region (*). Six motifs similar to the RSXSXP
14-3-3
-binding motif are indicated by lines with two
arrowheads.
(43, 44). Campbell et al. (44) showed that type I
5-phosphatase bound to the 14-3-3
via its RSXSXP motif (RSESEE).
We found six such motifs in the N- and C-terminal proline-rich regions
of PIPP (Fig. 1). PIPP contains the largest number of 14-3-3
-binding motifs of the known 5-phosphatases. Therefore, the
enzymatic activity of PIPP may be elevated by binding to 14-3-3
.
Fig. 2 shows the catalytic motifs of PIPP
that are conserved in other 5-phosphatases. Within the two motifs, the
amino acids shown to be essential for 5-phosphatase activity are
indicated by asterisks (45, 46) and are present in PIPP.

View larger version (19K):
[in a new window]
Fig. 2.
Comparison of characteristic amino acid
sequences of inositol polyphosphate 5-phosphatases with that of
PIPP. Two highly conserved motifs of 5-phosphatase are aligned
with PIPP. Asterisks (*) indicate the amino acids shown to
be important for 5-phosphatase activity (45, 46). The enzymes are
classified by specificity for substrates. Type I 5-phosphatase
hydrolyzes Ins(1,4,5)P3 and Ins(1,3,4,5)P4.
SHIP 1 and SHIP 2 react with the substrates that contain phosphate at
the D-33 position of the inositol ring, such as
PtdIns(3,4,5)P3. Type II 5-phosphatase, OCRL, and
synaptojanin hydrolyze Ins(1,4,5)P3,
Ins(1,3,4,5)P4, PtdIns(4,5)P2, and
PtdIns(3,4,5)P3. The GenBankTM accession
numbers are as follows: type I (X75094); SHIP 1 (U57650); SHIP 2 (Y14385); type II (M74161); OCRL (M88162); synaptojanin (U45479).

View larger version (33K):
[in a new window]
Fig. 3.
Immunoblotting of PIPP recombinant
protein. Recombinant PIPP was expressed in COS-7 cells and
detected by immunoblotting with anti-Myc polyclonal antibody
(left). Cell lysate incubated without calf intestine
alkaline phosphatase (CIAP) for 15 min at 30 °C
(middle), and with calf intestine alkaline phosphatase
(right).

View larger version (39K):
[in a new window]
Fig. 4.
Northern blot analysis of PIPP. Rat
PIPP-specific 0.7-kb cDNA probe detected an approximately 3.4-kb
band. The numbers depicted on the left are molecular weight
markers (left and middle panels) and positions of
ribosomal RNA (right panel). C6, rat glioma cells; A431,
human epidermoid carcinoma cells; C2C12, mouse myoblast cells; NIH 3T3,
mouse fibroblast cells; NIH 3T3(Ras), Ras-transformed NIH 3T3 cells;
COS-7 cells, simian kidney cells; Jurkat, human leukemic T cells;
HL-60, human myeloblastic leukemia cells.

View larger version (20K):
[in a new window]
Fig. 5.
Inositol polyphosphate 5-phosphatase activity
of PIPP. Hydrolysis of Ins(1,4,5)P3 (A) and
Ins(1,3,4,5)P4 (B) by recombinant PIPP. PIPP,
Myc-epitope-tagged PIPP protein was purified by immunoprecipitation and
incubated with substrate (
). Mock, cells containing the Myc-epitope
vector pCMV6-Myc were treated in the same manner (
). Recombinant
PIPP or mock was incubated with each substrate for 15 min, and the
reaction mixture was analyzed by high performance liquid
chromatography. When Ins(1,3,4)P3 was used as a substrate,
no hydrolysis was observed (C).

View larger version (59K):
[in a new window]
Fig. 6.
Lipid phosphatase activity of PIPP.
[3H]PtdIns(4,5)P2 was incubated with PIPP or
mock, and the reaction product was analyzed by thin layer
chromatography. In the PIPP lane, PtdIns(4,5)P2 hydrolysis
was observed, but no hydrolysis was observed when mock was incubated
with PtdIns(4,5)P2.

View larger version (66K):
[in a new window]
Fig. 7.
Expression of recombinant PIPP in COS-7
cells. Recombinant PIPP was expressed in COS-7 cells and
visualized with anti-Myc polyclonal antibody and fluorescein
isothiocyanate-conjugated anti-rabbit IgG antibody (A). The
same cells were stained with rhodamine-phalloidin (B).
-binding motifs in the proline-rich regions that are
involved in its cellular distribution. The identification of
PIPP-binding proteins should deepen the understanding of the function
of PIPP.

View larger version (33K):
[in a new window]
Fig. 8.
Cellular localization of PIPP and its
deletion mutants in COS-7 cells. Panel I, structure of
recombinant PIPP and its deletion mutants. All constructs had an
N-terminal Myc-epitope tag (gray box). N- and C-terminal
proline-rich regions are indicated by shaded boxes. The two
5-phosphatase catalytic motifs are indicated by black boxes.
The amino acid number of the deleted points are indicated at the
top. Panel II, cellular localization of PIPP and
its deletion mutants. Wild type (A and B); Mut4
(C and D); Mut6 (E and F);
Mut5 (G and H), and Mut1 (I and
J). Recombinant PIPP and its deletion mutants were stained
with anti-Myc polyclonal antibody and fluorescein
isothiocyanate-conjugated anti-rabbit IgG antibody (A,
C, E, G, and I). Active
Rac1 mutant was detected with anti-FLAG monoclonal antibody and
rhodamine-conjugated anti-mouse IgG antibody (B,
D, F, H, and J).
| |
FOOTNOTES |
|---|
* This work was supported in part by a grant-in-aid for Research for the Future Program from the Japan Society for the Promotion of Science.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Tel.: 81-3-5449-5508;
Fax: 81-3-5449-5417; E-mail: takenawa@ims.u-tokyo.ac.jp.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
Ins(1, 4,5)P3, inositol 1,4,5-trisphosphate;
kb, kilobase;
PBS(
), phosphate-buffered saline without Ca2+ and
Mg2+;
TLC, thin layer chromatography;
Ins(1, 3,4)P3, inositol 1,3,4-trisphosphate;
Ins(1, 3,4,5)P4, inositol 1,3,4,5-tetrakisphosphate;
PtdIns(4, 5)P2, phosphatidylinositol 4,5-bisphosphate;
PtdIns(3, 4,5)P3, phosphatidylinositol 3,4,5-trisphosphate;
EST, expressed sequence tag data base;
SHIP 1, SH2 containing inositol
polyphosphate 5-phosphatase 1.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ross, T. S.,
Jefferson, A. B.,
Mitchell, C. A.,
and Majerus, P. W.
(1991)
J. Biol. Chem.
266,
20283-20289 |
| 2. | Attree, O., Olivos, I. M., Okabe, I., Bailey, L. C., Nelson, D. L., Lewis, R. A., McInnes, R. R., and Nussbaum, R. L. (1992) Nature 358, 239-242[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Verjans, B., De Smedt, F., Lecocq, R., Vanweyenberg, V., Moreau, C., and Erneux, C. (1994) Biochem. J. 300, 85-90 |
| 4. | Hejna, J. A., Saito, H., Merkens, L. S., Tittle, T. V., Jakobs, P. M., Whitney, M. A., Grompe, M., Friedberg, A. S., and Moses, R. E. (1995) Genomics 29, 285-287[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Damen, J. E.,
Liu, L.,
Rosten, P.,
Humphries, R. K.,
Jefferson, A. B.,
Majerus, P. W.,
and Krystal, G.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1689-1693 |
| 6. | McPherson, P. S., Garcia, E. P., Slepnev, V. I., David, C., Zhang, X., Grabs, D., Sossin, W. S., Bauerfeind, R., Nemoto, Y., and De Camilli, P. (1996) Nature 379, 353-357[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Kavanaugh, W. M., Pot, D. A., Chin, S. M., Deuter-Reinhard, M., Jefferson, A. B., Norris, F. A., Masiarz, F. R., Cousens, L. S., Majerus, P. W., and Williams, L. T. (1996) Curr. Biol. 6, 438-445[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Lioubin, M. N.,
Algate, P. A.,
Tsai, S.,
Carlberg, K.,
Aebersold, A.,
and Rohrschneider, L. R.
(1996)
Genes Dev.
10,
1084-1095 |
| 9. | Pesesse, X., Deleu, S., De Smedt, F., Drayer, L., and Erneux, C. (1997) Biochem. Biophys. Res. Commun. 239, 697-700[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Haffner, C., Takei, K., Chen, H., Ringstad, N., Hudson, A., Butler, M. H., Salcini, A. E., Di Fiore, P. P., and De Camilli, P. (1997) FEBS Lett. 419, 175-180[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Nemoto, Y.,
Arribas, M.,
Haffner, C.,
and DeCamilli, P.
(1997)
J. Biol. Chem.
272,
30817-30821 |
| 12. |
Khvotchev, M.,
and Sudhof, T. C.
(1998)
J. Biol. Chem.
273,
2306-2311 |
| 13. | Seet, L. F., Cho, S., Hessel, A., and Dumont, D. J. (1998) Biochem. Biophys. Res. Commun. 247, 116-122[CrossRef][Medline] [Order article via Infotrieve] |
| 14. |
Matzaris, M.,
O'Malley, C. J.,
Badger, A.,
Speed, C. J.,
Bird, P. I.,
and Mitchell, C. A.
(1998)
J. Biol. Chem.
273,
8256-8267 |
| 15. | Woscholski, R., Finan, P. M., Radley, E., and Parker, P. J. (1998) FEBS Lett. 432, 5-8[CrossRef][Medline] [Order article via Infotrieve] |
| 16. |
Zhang, X.,
Jefferson, A. B.,
Auethavekiat, V.,
and Majerus, P. W.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4853-4856 |
| 17. | Pesesse, X., Moreau, C., Drayer, A. L., Woscholski, R., Parker, P., and Erneux, C. (1998) FEBS Lett. 437, 301-303[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Wisniewski, D.,
Strife, A.,
Swendeman, S.,
Erdjument-Bromage, H.,
Geromanos, S.,
Kavanaugh, W. M.,
Tempst, P.,
and Clarkson, B.
(1999)
Blood
93,
2707-2720 |
| 19. |
Woscholski, R.,
Finan, P. M.,
Radley, E.,
Totty, N. F.,
Sterling, A. E.,
Hsuan, J. J.,
Waterfield, M. D.,
and Parker, P. J.
(1997)
J. Biol. Chem.
272,
9625-9628 |
| 20. |
Zhang, X.,
Hartz, P. A.,
Philip, E.,
Racusen, L. C.,
and Majerus, P. W.
(1998)
J. Biol. Chem.
273,
1574-1582 |
| 21. |
Majerus, P. W.,
Kisseleva, M. V.,
and Norris, F. A.
(1999)
J. Biol. Chem.
274,
10669-10672 |
| 22. | Sakisaka, T., Itoh, T., Miura, K., and Takenawa, T. (1997) Mol. Cell. Biol. 17, 3841-3849[Abstract] |
| 23. |
Ma, A. D.,
Metjian, A.,
Bagrodia, S.,
Taylor, S.,
and Abrams, C. S.
(1998)
Mol. Cell. Biol.
18,
4744-4751 |
| 24. |
Vollenweider, P.,
Clodi, M.,
Martin, S. S.,
Imamura, T.,
Kavanaugh, W. M.,
and Olefsky, J. M.
(1999)
Mol. Cell. Biol.
19,
1081-1091 |
| 25. |
Fukami, K.,
Endo, T.,
Imamura, M.,
and Takenawa, T.
(1994)
J. Biol. Chem.
269,
1518-1522 |
| 26. | Lassing, I., and Lindberg, U. (1985) Nature 314, 472-474[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Janmey, P. A., and Stossel, T. P. (1987) Nature 325, 362-364[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Oh, E. S.,
Woods, A.,
Lim, S. T.,
Theibert, A. W.,
and Couchman, J. R.
(1998)
J. Biol. Chem.
273,
10624-10629 |
| 29. |
Liscovitch, M.,
Chalifa, V.,
Pertile, P.,
Chen, C. S.,
and Cantley, L. C.
(1994)
J. Biol. Chem.
269,
21403-21406 |
| 30. |
Pappan, K.,
Qin, W.,
Dyer, J. H.,
Zheng, L.,
and Wang, X.
(1997)
J. Biol. Chem.
272,
7055-7061 |
| 31. | Alessi, D. R., and Cohen, P. (1998) Curr. Opin. Genet. Dev. 8, 55-62[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Huang, C. L., Feng, S., and Hilgemann, D. W. (1998) Nature 391, 803-806[CrossRef][Medline] [Order article via Infotrieve] |
| 33. |
Shyng, S. L.,
and Nichols, C. G.
(1998)
Science
282,
1138-1141 |
| 34. |
Baukrowitz, T.,
Schulte, U.,
Oliver, D.,
Herlitze, S.,
Krauter, T.,
Tucker, S. J.,
Ruppersberg, J. P.,
and Fakler, B.
(1998)
Science
282,
1141-1144 |
| 35. |
Randazzo, P. A.
(1997)
J. Biol. Chem.
272,
7688-7692 |
| 36. |
Connolly, T. M.,
Bross, T. E.,
and Majerus, P. W.
(1985)
J. Biol. Chem.
260,
7868-7874 |
| 37. | Zhang, L., and Buxton, I. L. O. (1998) in Phospholipid Signaling Protocols (Bird, I. M., ed) , pp. 47-63, Humana Press, Totowa, NJ |
| 38. |
Matzaris, M.,
Jackson, S. P.,
Laxminarayan, K. M.,
Speed, C. J.,
and Mitchell, C. A.
(1994)
J. Biol. Chem.
269,
3397-3402 |
| 39. |
Kozak, M.
(1991)
J. Cell Biol.
115,
887-903 |
| 40. |
Sadler, I.,
Crawford, A. W.,
Michelsen, J. W.,
and Beckerle, M. C.
(1992)
J. Cell Biol.
119,
1573-1587 |
| 41. | Lim, W. A., Richards, F. M., and Fox, R. O. (1994) Nature 372, 375-379[CrossRef][Medline] [Order article via Infotrieve] |
| 42. |
Feng, S.,
Chen, J. K., Yu, H.,
Simon, J. A.,
and Schreiber, S. L.
(1994)
Science
266,
1241-1247 |
| 43. |
Auethavekiat, V.,
Abrams, C. S.,
and Majerus, P. W.
(1997)
J. Biol. Chem.
272,
1786-1790 |
| 44. | Campbell, J. K., Gurung, R., Romero, S., Speed, C. J., Andrews, R. K., Berndt, M. C., and Mitchell, C. A. (1997) Biochemistry 36, 15363-15370[CrossRef][Medline] [Order article via Infotrieve] |
| 45. |
Communi, D.,
Lecocq, R.,
and Erneux, C.
(1996)
J. Biol. Chem.
271,
11676-11683 |
| 46. | Jefferson, A. B., and Majerus, P. W. (1996) Biochemistry 35, 7890-7894[CrossRef][Medline] [Order article via Infotrieve] |
| 47. |
Shibasaki, Y.,
Ishihara, H.,
Kizuki, N.,
Asano, T.,
Oka, Y.,
and Yazaki, Y.
(1997)
J. Biol. Chem.
272,
7578-7581 |
| 48. | Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., and Hall, A. (1992) Cell 70, 401-410[CrossRef][Medline] [Order article via Infotrieve] |
| 49. |
Hall, A.
(1998)
Science
279,
509-514 |
This article has been cited by other articles:
![]() |
L. M. Ooms, C. G. Fedele, M. V. Astle, I. Ivetac, V. Cheung, R. B. Pearson, M. J. Layton, A. Forrai, H. H. Nandurkar, and C. A. Mitchell The Inositol Polyphosphate 5-Phosphatase, PIPP, Is a Novel Regulator of Phosphoinositide 3-Kinase-dependent Neurite Elongation Mol. Biol. Cell, February 1, 2006; 17(2): 607 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kumar, P. Zhao, A. Tomar, C. A. Galea, and S. Khurana Association of Villin with Phosphatidylinositol 4,5-Bisphosphate Regulates the Actin Cytoskeleton J. Biol. Chem., January 23, 2004; 279(4): 3096 - 3110. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gurung, A. Tan, L. M. Ooms, M. J. McGrath, R. D. Huysmans, A. D. Munday, M. Prescott, J. C. Whisstock, and C. A. Mitchell Identification of a Novel Domain in Two Mammalian Inositol-polyphosphate 5-Phosphatases That Mediates Membrane Ruffle Localization. THE INOSITOL 5-PHOSPHATASE SKIP LOCALIZES TO THE ENDOPLASMIC RETICULUM AND TRANSLOCATES TO MEMBRANE RUFFLES FOLLOWING EPIDERMAL GROWTH FACTOR STIMULATION J. Biol. Chem., March 21, 2003; 278(13): 11376 - 11385. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. O'Luanaigh, R. Pardo, A. Fensome, V. Allen-Baume, D. Jones, M. R. Holt, and S. Cockcroft Continual Production of Phosphatidic Acid by Phospholipase D Is Essential for Antigen-stimulated Membrane Ruffling in Cultured Mast Cells Mol. Biol. Cell, October 1, 2002; 13(10): 3730 - 3746. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Laporte, F. Blondeau, A. Gansmuller, Y. Lutz, J.-L. Vonesch, and J.-L. Mandel The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles J. Cell Sci., January 8, 2002; 115(15): 3105 - 3117. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Dyson, C. J. O'Malley, J. Becanovic, A. D. Munday, M. C. Berndt, I. D. Coghill, H. H. Nandurkar, L. M. Ooms, and C. A. Mitchell The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin J. Cell Biol., December 10, 2001; 155(6): 1065 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Communi, K. Gevaert, H. Demol, J. Vandekerckhove, and C. Erneux A Novel Receptor-mediated Regulation Mechanism of Type I Inositol Polyphosphate 5-Phosphatase by Calcium/Calmodulin-dependent Protein Kinase II Phosphorylation J. Biol. Chem., October 12, 2001; 276(42): 38738 - 38747. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Botelho, M. Teruel, R. Dierckman, R. Anderson, A. Wells, J. D. York, T. Meyer, and S. Grinstein Localized Biphasic Changes in Phosphatidylinositol-4,5-Bisphosphate at Sites of Phagocytosis J. Cell Biol., December 18, 2000; 151(7): 1353 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ijuin, Y. Mochizuki, K. Fukami, M. Funaki, T. Asano, and T. Takenawa Identification and Characterization of a Novel Inositol Polyphosphate 5-Phosphatase J. Biol. Chem., April 6, 2000; 275(15): 10870 - 10875. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Kong, C. J. Speed, C. J. O'Malley, M. J. Layton, T. Meehan, K. L. Loveland, S. Cheema, L. M. Ooms, and C. A. Mitchell Cloning and Characterization of a 72-kDa Inositol-polyphosphate 5-Phosphatase Localized to the Golgi Network J. Biol. Chem., July 28, 2000; 275(31): 24052 - 24064. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |